Articles by Disease (Kaposi's Sarcoma)

Thalidomide in Multiple Myeloma

Journal: Current Pharmaceutical Biotechnology
Volume: 7
Page: 431-440
Author(s): T. M. Moehler, J. Hillengass, A. Glasmacher and H. Goldschmidt

The Pathology Induced by Highly Active Antiretroviral Therapy Against Human Immunodeficiency Virus: an Update

Journal: Current Medicinal Chemistry
Volume: 13
Page: 3121-3132
Author(s): Paul Hofman and Ann Marie Nelson

Molecular Imaging of Matrix Metalloproteinases In Vivo Using Small Molecule Inhibitors for SPECT and PET

Journal: Current Medicinal Chemistry
Volume: 13
Page: 2819-2838
Author(s): S. Wagner, H.-J. Breyholz, A. Faust, C. Holtke, B. Levkau, O. Schober, M. Schafers and K. Kopka

Potential Deployment of Angiotensin I Converting Enzyme Inhibitors and of Angiotensin II Type 1 and Type 2 Receptor Blockers in Cancer Chemotherapy

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 6
Page: 451-460
Author(s): Agostino Molteni, Sue Heffelfinger, John E. Moulder, Bruce Uhal and William J. Castellani

STAT3: A Molecular Target for Cancer Whose Time Has Come

Journal: Current Signal Transduction Therapy
Volume: 1
Page: 239-253
Author(s): Beverly E. Barton

Cytokines and Chemokines as Regulators of Angiogenesis in Health and Disease

Journal: Current Pharmaceutical Design
Volume: 12
Page: 3101-3115
Author(s): R. Benelli, G. Lorusso, A. Albini and D. M. Noonan

Immunotherapeutic and Immunoregulatory Drugs in Haematologic Malignancies

Journal: Current Topics in Medicinal Chemistry
Volume: 6
Page: 1657-1686
Author(s): Gerassimos A. Pangalis, Marie-Christine Kyrtsonis, Theodoros P. Vassilakopoulos, Maria N. Dimopoulou, Marina P. Siakantaris, Christos Emmanouilides, Dimitris Doufexis, Sotirios Sahanas, Flora N. Kontopidou, Christina Kalpadakis, Maria K. Angelopoulou, Evangelia M. Dimitriadou, Styliani I. Kokoris and Panayiotis Panayiotidis